NKTX

Nkarta, Inc.

9.55 USD
+0.02 (+0.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nkarta, Inc. stock is up 20.73% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
29 Dec 20:34 16 Feb, 2024 7.50 CALL 420 72
08 Jan 20:57 16 Aug, 2024 12.50 CALL 70 10

About Nkarta, Inc.

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens.